Skip to main content
WP

www.puhengtec.com

Puheng Biomedicine develops in vitro 3D organ and disease models using its proprietary NAC-Organ technology, which enables rapid, high-throughput production of complex humanized models for chronic diseases and tumors. This technology addresses the inefficiencies in drug research and development by providing accurate and standardized platforms for drug screening and testing.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Traditional drug discovery and development processes rely heavily on animal models and 2D cell cultures, which often fail to accurately replicate human physiology and disease states. This leads to high failure rates in clinical trials and increased costs in bringing new drugs to market. There is a need for more predictive and human-relevant in vitro models for drug screening and testing.

Solution

Puheng Biomedicine offers in vitro 3D organ and disease models using its proprietary NAC-Organ technology, enabling rapid and high-throughput production of complex, humanized models for chronic diseases and tumors. The NAC-Organ technology facilitates the self-assembly of cells in a three-dimensional space, allowing precise control over cell types, quantities, and spatial distribution. These 3D models, including liver models containing hepatocytes and non-parenchymal cells, can be stably cultured in vitro for extended periods, maintaining high levels of cell secretion and function. Puheng's platform provides accurate and standardized platforms for drug screening, drug testing, and regenerative medicine technology development, improving the efficiency and predictability of preclinical research.

Target Audience

The primary customers are pharmaceutical companies, biotechnology firms, and research institutions involved in drug discovery, preclinical research, and regenerative medicine.

Features

  • NAC-Organ technology for rapid assembly of 3D cell cultures
  • Ability to create complex, humanized models of various organs and diseases
  • 3D liver model (NAC-Liver) containing hepatocytes and non-parenchymal cells
  • Stable in vitro culture for over 30 days with high levels of cell secretion
  • Automated cultivation system for high-throughput model cultivation and testing
  • Customizable 3D model development services
  • Drug screening and testing services using 3D models
  • Anti-tumor and NASH drug testing services
This profile is AI-generated and may contain inaccuracies.